abstract |
The present invention relates to a method for treating anthrax or inhibiting lethal factors by administering a compound of formula (I) and a composition comprising a compound of formula (I) and a pharmaceutically acceptable carrier. The invention further relates to the use of a compound of formula (I) in treating other conditions associated with anthrax infection. |